NCT00509275View on ClinicalTrials.gov

A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP)

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Tinea Pedis
Interventions
DRUG

W0027

capsule

DRUG

Placebo

Placebo

Trial Locations (9)

40202

Dermatology Specialists, Louisville

45219

University Dermatology Consultants, Inc., Cincinnati

48088

Warren

87106

Albuquerque

NSW 2217

St George Dermatology and Skin Cancer Centre, Kogarah

QLD 4217

The Skin Centre, Benowa

QLD 4152

South East Dermatology, Carina

SA 5006

Dermatology on Ward, North Adelaide

VIC 3053

Skin and Cancer Foundation, Carlton

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Stiefel, a GSK Company

INDUSTRY